These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2161065)

  • 1. Effects of the DNA topoisomerase II inhibitor, VM26, on transcriptional initiation in vitro.
    Preston GM; White BA
    Life Sci; 1990; 46(18):1309-18. PubMed ID: 2161065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.
    Minocha A; Long BH
    Biochem Biophys Res Commun; 1984 Jul; 122(1):165-70. PubMed ID: 6331440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.
    Schaak J; Schedl P; Shenk T
    Nucleic Acids Res; 1990 Mar; 18(6):1499-508. PubMed ID: 2158079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
    Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A; Strausfeld U; Knippers R
    Nucleic Acids Res; 1987 Apr; 15(8):3455-68. PubMed ID: 3033604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of topoisomerase II in the Ca2+-dependent basal level expression of the rat prolactin gene.
    White BA; Preston GM
    Mol Endocrinol; 1988 Jan; 2(1):40-6. PubMed ID: 2840567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
    Hwang JL; Shyy SH; Chen AY; Juan CC; Whang-Peng J
    Cancer Res; 1989 Feb; 49(4):958-62. PubMed ID: 2536295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin.
    Rowe TC; Wang JC; Liu LF
    Mol Cell Biol; 1986 Apr; 6(4):985-92. PubMed ID: 3023886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of topoisomerase II activity and its effect on nucleolar structure and function.
    Govoni M; Farabegoli F; Pession A; Novello F
    Exp Cell Res; 1994 Mar; 211(1):36-41. PubMed ID: 7510250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete reversion of double stranded DNA cleavage mediated by Drosophila topoisomerase II: formation of single stranded DNA cleavage complex in the presence of an anti-tumor drug VM26.
    Lee MP; Hsieh T
    Nucleic Acids Res; 1992 Oct; 20(19):5027-33. PubMed ID: 1329036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of topoisomerase II does not inhibit transcription of RNA polymerase I and II genes.
    Dunaway M
    Mol Cell Biol; 1990 Jun; 10(6):2893-900. PubMed ID: 2160588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
    Yang L; Rowe TC; Liu LF
    Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Bugg BY; Danks MK; Beck WT; Suttle DP
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.
    Fernandes DJ; Danks MK; Beck WT
    Biochemistry; 1990 May; 29(17):4235-41. PubMed ID: 2163274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
    Furukawa M; Harada T; Tanaka T; Kuwano M
    Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.